Search

Your search keyword '"McRae, Simon"' showing total 288 results

Search Constraints

Start Over You searched for: Author "McRae, Simon" Remove constraint Author: "McRae, Simon"
288 results on '"McRae, Simon"'

Search Results

1. Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study

2. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

4. Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis

5. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis

9. Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study

10. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

11. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

12. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion

13. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

14. Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)

19. sj-docx-1-tah-10.1177_20406207221085202 – Supplemental material for International consensus recommendations on the management of people with haemophilia B

22. International consensus recommendations on the management of people with haemophilia B

23. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis

24. Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study)

25. von Willebrand disease: proposing definitions for future research

29. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity

36. Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivopatient samples

50. How to use low-molecular-weight heparin to prevent DVT: low-molecular-weight heparin, a major advance in the treatment of deep vein thrombosis, is also a vastly underused means of preventing this disorder. Here are recommendations on how and when to use this medication

Catalog

Books, media, physical & digital resources